Hong Kong Life Sciences and Technologies Group Limited provided earnings guidance for the three months ended June 30, 2019. The board of directors of the company informed the shareholders of the company and potential investors that based on information currently available to the Company, the Group is expected to record a loss for the three months period ended 30 June 2019 as compared to the profit of approximately HKD 4.5 million for the three months period ended 30 June 2018. The turnaround to loss for the First Quarterly Results was mainly due to the absence of the reversal of impairment loss on loan interest receivables for the same period last year and the increase in administrative and operating expenses for the new establishment of laboratory and customer service centre since March 2019.